Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer

Hideya Onishi, Mitsuo Katano

Research output: Contribution to journalArticlepeer-review

68 Citations (Scopus)


Pancreatic cancer is one of the most aggressive and difficult cancers to treat. Despite numerous research efforts, limited success has been achieved in the therapeutic management of patients with this disease. In the current review, we focus on one component of morphogenesis signaling, Hedgehog (Hh), with the aim of developing novel, effective therapies for the treatment of pancreatic cancer. Hh signaling contributes to the induction of a malignant phenotype in pancreatic cancer and is responsible for maintaining pancreatic cancer stem cells. In addition, we propose a novel concept linking Hh signaling and tumor hypoxic conditions, and discuss the effects of Hh inhibitors in clinical trials. The Hh signaling pathway may represent a potential therapeutic target for patients with refractory pancreatic cancer.

Original languageEnglish
Pages (from-to)2335-2342
Number of pages8
JournalWorld Journal of Gastroenterology
Issue number9
Publication statusPublished - 2014

All Science Journal Classification (ASJC) codes

  • Gastroenterology


Dive into the research topics of 'Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer'. Together they form a unique fingerprint.

Cite this